2012: Year in review
Recent articles
What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?
What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?
Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.
Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.
Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.
Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.
Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.
Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.
Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.
Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.
Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.
Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.
Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.
Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.
Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.
Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.
Explore more from The Transmitter
Targeting NMDA receptor subunit reverses fragile X traits in mice
The subunit acts as a “volume control” on signaling that shapes the density of dendritic spines, the new work suggests.
Targeting NMDA receptor subunit reverses fragile X traits in mice
The subunit acts as a “volume control” on signaling that shapes the density of dendritic spines, the new work suggests.
Maternal infection’s link to autism may be a mirage
Family-linked factors explain most associations between maternal illness and autism, a study of 1.1 million Danish children finds.
Maternal infection’s link to autism may be a mirage
Family-linked factors explain most associations between maternal illness and autism, a study of 1.1 million Danish children finds.
2025 Brain Prize honors pair of cancer neuroscientists
Michelle Monje and Frank Winkler share the $1.4 million award for their discovery of synapses between brain cancer cells and neurons.
2025 Brain Prize honors pair of cancer neuroscientists
Michelle Monje and Frank Winkler share the $1.4 million award for their discovery of synapses between brain cancer cells and neurons.